These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 5443382)

  • 41. Estimation of treatment dose in high-efficiency haemodialysis.
    Smye SW; Dunderdale E; Brownridge G; Will E
    Nephron; 1994; 67(1):24-9. PubMed ID: 8052363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of standard Kiil and pyramid-surface dialyzers.
    Yager H; Richardson JA
    JAMA; 1972 May; 220(8):1101-3. PubMed ID: 5067511
    [No Abstract]   [Full Text] [Related]  

  • 43. Acute effect of haemodialysis on arterial stiffness: membrane bioincompatibility?
    Mourad A; Carney S; Gillies A; Jones B; Nanra R; Trevillian P
    Nephrol Dial Transplant; 2004 Nov; 19(11):2797-802. PubMed ID: 15340092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Removal of β2-Microglobulin in Spent Dialysate Cannot Be Monitored by Spectrophotometric Analysis.
    Donadio C; Calia D; Ghimenti S; Onor M; Colombini E; Fuoco R; Di Francesco F
    Blood Purif; 2015; 40(2):109-12. PubMed ID: 26183959
    [No Abstract]   [Full Text] [Related]  

  • 45. Maintaining residual renal function in patients on haemodialysis: 5-year experience using a progressively increasing dialysis regimen.
    Fernández-Lucas M; Teruel-Briones JL; Gomis-Couto A; Villacorta-Pérez J; Quereda-Rodríguez-Navarro C
    Nefrologia; 2012; 32(6):767-76. PubMed ID: 23169359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
    Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determinants of haemodialyser performance and the potential effect on clinical outcome.
    Clark WR; Ronco C
    Nephrol Dial Transplant; 2001; 16 Suppl 5():56-60. PubMed ID: 11509686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Paediatric haemodialysis: estimation of treatment efficiency in the presence of urea rebound.
    Smye SW; Evans JH; Will E; Brocklebank JT
    Clin Phys Physiol Meas; 1992 Feb; 13(1):51-62. PubMed ID: 1563221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increasing dialysate flow rate increases dialyzer urea clearance and dialysis efficiency: an in vivo study.
    Azar AT
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1023-9. PubMed ID: 19861865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unexpected triggering of the dialysate blood leak detector by haemolysis.
    Lindley E; Finney D; Jones P; Lewington A; O'Reagan A; Webb G
    Acta Clin Belg; 2015 Jun; 70(3):226-9. PubMed ID: 25468361
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis.
    Teruel-Briones JL; Fernández-Lucas M; Rivera-Gorrin M; Ruiz-Roso G; Díaz-Domínguez M; Rodríguez-Mendiola N; Quereda-Rodríguez-Navarro C
    Nefrologia; 2013; 33(5):640-9. PubMed ID: 24089155
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HAEMODIALYSIS DISEQUILIBRIUM.
    ROSEN SM; O'CONNOR K; SHALDON S
    Br Med J; 1964 Sep; 2(5410):672-5. PubMed ID: 14171099
    [No Abstract]   [Full Text] [Related]  

  • 54. Cephaloridine serum levels in patients on maintenance haemodialysis.
    Curtis JR; Marshall MJ
    Br Med J; 1970 Apr; 2(5702):149-51. PubMed ID: 5440596
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phosphate, urea and creatinine clearances: haemodialysis adequacy assessed by weekly monitoring.
    Debowska M; Wojcik-Zaluska A; Ksiazek A; Zaluska W; Waniewski J
    Nephrol Dial Transplant; 2015 Jan; 30(1):129-36. PubMed ID: 25140013
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Haemodialysis in rats.
    Röckel A; Brand A; Stanjek A; Hevendehl G; Heidland A; Hoeltzenbein J; Pedersen FS
    Res Exp Med (Berl); 1978 Mar; 172(2):187-91. PubMed ID: 644141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PERITONEAL-EXTRACORPOREAL RECIRCULATION DIALYSIS A TECHNIQUE FOR IMPROVING EFFICIENCY OF PERITONEAL DIALYSIS.
    SHINABERGER JH; SHEAR L; BARRY KG
    Invest Urol; 1965 May; 2():555-66. PubMed ID: 14283599
    [No Abstract]   [Full Text] [Related]  

  • 58. Meltec Multipoint haemodialyser.
    Von Hartitzsch B; Hoenich NA
    Br Med J; 1972 Jan; 1(5794):237-9. PubMed ID: 5018283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The significance of transcellular transport kinetics of urea and creatinine for haemodialysis (author's transl)].
    Zimmermann E; Pölz E
    Wien Klin Wochenschr; 1981 Sep; 93(16):519-21. PubMed ID: 7303697
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Accuracy of hemodialysis modeling.
    Ziółko M; Pietrzyk JA; Grabska-Chrzastowska J
    Kidney Int; 2000 Mar; 57(3):1152-63. PubMed ID: 10720967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.